Current Neuropharmacology
Volume 19, 12 Issues, 2021
ISSN: 1875-6190 (Online)
ISSN: 1570-159X (Print)
This journal supports open access
ISSN: 1875-6190 (Online)
ISSN: 1570-159X (Print)
This journal supports open access
In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research
Contents
Current Neuropharmacology, Volume 14 - Number 3
LRRK2 Kinase Inhibition as a Therapeutic Strategy for Parkinson’s Disease, Where Do We Stand?
, 14(3): 214 - 225Jean-Marc Taymans and Elisa Greggio
DOI: 10.2174/1570159X13666151030102847
LRRK2 Kinase Inhibition as a Therapeutic Strategy for Parkinson’s Disease, Where Do We Stand?
Modulating the Amyloidogenesis of α-Synuclein
, 14(3): 226 - 237Kalkena Sivanesam and Niels H. Andersen
DOI: 10.2174/1570159X13666151030103153
Modulating the Amyloidogenesis of α-Synuclein
Targeting the Autophagy/Lysosomal Degradation Pathway in Parkinson´s Disease
, 14(3): 238 - 249Pilar Rivero-Ríos, Jesús Madero-Pérez,, Belén Fernández and Sabine Hilfiker
DOI: 10.2174/1570159X13666151030103027
Targeting the Autophagy/Lysosomal Degradation Pathway in Parkinson´s Disease
Counteracting PINK/Parkin Deficiency in the Activation of Mitophagy: A Potential Therapeutic Intervention for Parkinson’s Disease
, 14(3): 250 - 259Alice Nardin, Emilie Schrepfer and Elena Ziviani
DOI: 10.2174/1570159X13666151030104414
Counteracting PINK/Parkin Deficiency in the Activation of Mitophagy: A Potential Therapeutic Intervention for Parkinson’s Disease
Anti-Oxidants in Parkinson’s Disease Therapy: A Critical Point of View
, 14(3): 260 - 271Roberta Filograna, Mariano Beltramini, Luigi Bubacco and Marco Bisaglia
DOI: 10.2174/1570159X13666151030102718
Anti-Oxidants in Parkinson’s Disease Therapy: A Critical Point of View
Methylphenidate on Cognitive Improvement in Patients with Traumatic Brain Injury: A Meta-Analysis
, 14(3): 272 - 281Chi-Hsien Huang, Chia-Chen Huang, Cheuk-Kwan Sun, Gong-Hong Lin and Wen-Hsuan Hou
DOI: 10.2174/1570159X13666150514233033
Methylphenidate on Cognitive Improvement in Patients with Traumatic Brain Injury: A Meta-Analysis
Selenium in the Therapy of Neurological Diseases. Where is it Going?
, 14(3): 282 - 299Agnieszka Dominiak, Anna Wilkaniec, Piotr Wroczyński and Agata Adamczyk
DOI: 10.2174/1570159X14666151223100011
Selenium in the Therapy of Neurological Diseases. Where is it Going?
Editor-in-Chief
F. Nicoletti
University Rome"da Sapienza"
Rome
(Italy)
University Rome"da Sapienza"
Rome
COPE Compliant
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Neuropharmacology was introduced in 2003 and Dr. Ferdinando Nicoletti is the New Editor-in-Chief of the journal, appointed in 2019.
Scopus CiteScore Metrics: 4.72
New eBook
 |
Neurobiology of Mood DisordersYou can view the contents of this eBook [here] or purchase it [here]. |
Webmaster Contact: info@benthamscience.net